Europe/India/Near East USA Asia
Bachem AG Bachem Americas, Inc. Bachem Japan K.K.
Hauptstrasse 144 3132 Kashiwa Street AREA Shinagawa, 13F
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA Tokyo 108-0075 - Japan
Tel +41 58 595 2021 Tel +1 888 422 2436 Tel +81 3 4405 3141
Fax +41 58 595 2040 Tel +1 888 4BACHEM Email
Email Fax +1 310 539 9428  


Honorary Chairman


Peter Grogg (1942) Dr. h.c., Honorary Chairman, Swiss
Peter Groggsince 1971
Honorary Chairman
Peter Grogg founded Bachem AG in 1971 and was the CEO until 2002 and Chairman of the Board of Bachem Holding AG until 2012. He is Chairman of the Board of Ingro Finanz AG.


Board of Directors


Kuno Sommer (1956) 1, Ph.D. in Business Administration, Chairman, Swiss
Kuno Sommer since 2012, elected until 2019
Dr. Kuno Sommer, Ph.D. University of Basel, worked for Roche from 1986 to 1999 in various functions, including four years  in the USA. Kuno Sommer was ultimately a member of the Executive Committee of Roche, responsible for the Flavours and Fragrances division, today Givaudan. From 2000 to 2006 he was CEO of Berna Biotech. Kuno Sommer is Vice-Chairman of the Board of Polyphor AG, Chairman of the Board of Sunstar Holding AG, of PDS Pathology Data Systems AG, of Kenta Biotech AG and of Targimmune Therapeutics AG.
Nicole-Grogg-HoetzerNicole Grogg Hötzer (1973), Graduate Biologist, Vice-Chairwoman, Swiss
Nicole Grogg Hötzersince 2011, elected until 2019
Nicole Grogg Hötzer graduated in Biology at Basel University in 1999. Afterwards, she worked in various positions in the field of regulatory affairs. In 2002 Nicole Grogg Hötzer began her postgraduate studies in Business Administration at the University of Applied Sciences Basel which she completed successfully in 2004. Nicole Grogg Hötzer is Vice Chairwoman of the Board of Directors of Ingro Finanz AG, of Hotel Bad Schauenburg AG and of Sunstar Holding AG as well as member of the Board of Directors of MFC Beteiligungs AG and of Breiten Immobilien AG.
Jürgen Brokatzky-Geiger (1952) 1, Dr. rer.nat., Member, German
Jürgen Brokatzky-since 2009, elected until 2019
MemberDr. Jürgen Brokatzky-Geiger graduated with a Ph.D. in chemistry from the University of Freiburg, Germany, in 1982. He joined Ciba-Geigy Ltd. in 1983 as a Laboratory Head in the Pharmaceuticals Division. After a job rotation in the United States, he held positions of increasing responsibility in Research and Development (R&D) including Group Leader of Process R&D, Head of Process R&D, and Head of Process Development and Pilot Plant Operations. During the merger of Ciba-Geigy and Sandoz in 1996, Dr. Jürgen Brokatzky-Geiger was appointed Integration Officer of Technical Operations. He later became the Head of Chemical and Analytical Development and served as the Global Head of Technical R&D from 1999 to August 2003. From September 2003 to February 2014, he was appointed as Global Head of Human Resources and member of the Executive Committee of Novartis. Until his retirement at the end of October 2017, Dr. Jürgen Brokatzky-Geiger was Global Head of Corporate Responsibility of Novartis..
Thomas Burckhardt (1950) Dr. iur., LL.M., Member, Secretary of the Board, Swiss
Thomas Burckhardtsince 1997, elected until 2019

Member, Secretary

of the Board

Thomas Burckhardt studied at the universities of Basel, Geneva and Munich and was awarded his doctorate in 1978 in Basel. Since 1975, he is admitted to the bar and in 1979, he received a Master of Law (LL.M.) at Harvard Law School (Cambridge, Massachusetts, US). Since 1980, he is practicing as lawyer in Zurich and Basel and since 1987, he is a partner at Simonius Pfrommer & Partner in Basel. Thomas Burckhardt further is Honorary Consul-General of the Kingdom of Thailand in Basel. Other important Board memberships: MFC Beteiligungs AG and Stiftung FOCUS Basel.
Helma Wennemers (1969) Prof. Dr., Member, German
Helma Wennemerssince 2014, elected until 2019
Helma Wennemers graduated with a diploma degree in chemistry from Johann-Wolfgang-Goethe University in Frankfurt in 1993. Three years later she earned a doctorate degree from Columbia University, New York. She then pursued post-doctoral studies at Nagoya University before accepting the "Bachem-Stiftungs-Assistenzprofessur" at the University of Basel in 1999, where she became Associate Professor in 2003. Since 2011, she is Professor at the Laboratory of Organic Chemistry at ETZ Zürich. Helma Wennemers research has been recognized by several awards including the "Inhoffen Medal" (2017), the "Pedler Award" (2016) and the "Leonidas Zervas Award" (2010). She has also been awarded with numerous honorary lectureships such as the "Calvin Lecture" of UC Berkeley (2017), "The Chemical Record Lectureship" (2017), the "David Ginsburg Lectureship" at the Technion in Haifa (2010) and was named a "Fellow of the Royal Society of Chemistry" (2013).
Rolf Nyfeler (1950) 1, Dr. phil. II, Member, Swiss
Rolf Nyfelersince 2012, elected until 2019
Rolf Nyfeler studied chemistry at Basel University and was awarded his doctorate in 1979. Afterwards he deepened his knowledge with postdoc stays at the Max-Planck-Institute in Martinsried and at the University of California in San Diego. Rolf Nyfeler joined Bachem in 1982. For many years he was responsible for Research and Development in Bubendorf. Then, after spending some time as Head of Production in the subsidiary in California, he became COO of the Parent company in 1998. From 2002 to 2012, he was CEO of the Bachem Group and Chairman of the Corporate Executive Committee.
1 Member of the Compensation Committee

Corporate Executive Committee


Thomas FrühThomas Früh (1957) Dr. chem. ETH, CEO, Swiss
Thomas Früh since 2012
Thomas Früh joined Bachem in 1997. He was first COO of the Bachem Group Company in Pennsylvania and became COO of Bachem AG in 2001. Since April 1, 2012 he is CEO of Bachem Holding AG and Chairman of the Corporate Executive Committee. He completed his education as a chemist at the Swiss Federal Institute of Technology in Zürich (ETH) and then was research fellow at Harvard University in Cambridge. Before he joined Bachem, he held various research and development positions at Ciba-Geigy and Novartis. Thomas Früh is member of the Board of Directors of Dottikon ES Holding AG, Board member of the business association scienceindustries and the Chamber of Commerce of both Basel as well as President of the Board of the foundation SimplyScience.

Anne-Kathrin Stoller (1974) Dr. phil. nat., CMO, German
Anne-Kathrin Stollersince 2018
Anne-Kathrin Stoller joined Bachem AG in Bubendorf in 2006 and headed the Business Development Unit from 2008 to 2010. Subsequently, she was responsible for the Business Development & Sales Department, first locally and finally for the entire region Europe. Serving as Vice President and Department Head she was also a member of the local management team in Bubendorf. Since January 1, 2018, she is CMO of the Bachem Group and member of the Corporate Executive Committee. Anne-Kathrin Stoller studied chemistry in Hannover (Germany) and Cambridge (UK). After obtaining her doctorate under the supervision of Prof. Dr. Bernd Giese at the University of Basel (Switzerland), she started her career in the sales team of Exxonmobil Chemical.

Thomas Meier (1968) Degree in Chemistry and as Industrial Engineer, COO, Swiss
Thomas Meiersince 2019

Thomas Meier joined Bachem AG in 1993 as Team Head, Active Pharmaceutical Ingredients. From 2001 to 2004, he headed up peptide manufacturing at Peninsula Laboratories, Inc. in San Carlos, California. On his return to Switzerland, he was in charge of solid-phase peptide manufacturing for Bachem AG in Bubendorf. He assumed overall responsibility for production at the Bubendorf site in 2013, and was appointed COO Europe in August 2017, with responsibility for all production sites in Switzerland, Germany and the UK. He was appointed COO of the Bachem Group and member of the Corporate Executive Committee effective January 1, 2019. After an apprenticeship as chemical laboratory technician at the ETH in Zurich, Thomas Meier obtained a degree in chemistry from the ZHAW School of Engineering. Parallel to working, he obtained a degree as Industrial Engineer STA (Swiss Technical Association) and completed the Advanced Management Program at INSEAD Business School, Fontainebleau/Paris.



Guenther LoidlGuenther Loidl (1970) Dr. rer. nat., CTO, German
CTOsince 2015
Guenther Loidl joined Bachem in 2000. He held several functions in Research and Development (R&D) and Active Pharmaceutical Ingredient Manufacturing and became Vice President R&D in 2012. Since 2015, he is CTO of the Bachem Group and a member of the Corporate Executive Committee. He studied chemistry in Regensburg (Germany) and Leeds (UK) and obtained his doctorate under the supervision of Prof. Dr. Luis Moroder at the Max Planck Institute of Biochemistry in Martinsried (Germany).


Stephan Schindler (1964) business economist HWV, EMBA, CFO, Swiss
Stephan Schindlersince 2009
Stephan Schindler joined Bachem Holding AG as Chief Financial Officer (CFO) and member of the Corporate Executive Committee in 2009. In 1991, he assumed a first management position in informatics as Head of Information Center at Patria Insurances in Basel. In parallel, he persistently pursued his extra occupational studies in business economics, finance and control. After his graduation, he joined F. Hoffmann- La Roche Ltd in Basel where he assumed various positions in Corporate Finance. With the unbundling of the division in 2001, he took over the accounting & reporting department at Roche Vitamins Ltd. Until 2009, he was Head Finance & Control Switzerland at DSM Nutritional Products Ltd, Kaiseraugst. Stephan Schindler holds a degree of International Executive MBA Zurich/Boston. Furthermore, he is a member of the Board of Directors of Arcondis (Holding) AG and a Board member of Columna Collective Foundation - Client Invest, Winterthur.